Skip to main content
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED logo

MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED — Investor Relations & Filings

Ticker · 544673 ISIN · INE1HK501016 LEI · 9845002B7ND39C436A58 BSE.NS Human health and social work activities
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 544673

About MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED

https://www.mdrcindia.com

Modern Diagnostic & Research Centre Limited is a healthcare provider specializing in comprehensive diagnostic and imaging services. The organization operates a network of advanced facilities offering a broad spectrum of pathology and radiology investigations, including high-resolution MRI, multi-slice CT scans, digital X-rays, and ultrasound. Its laboratory services encompass clinical chemistry, hematology, immunology, and molecular diagnostics. The company is characterized by its adherence to international quality standards, maintaining NABL and NABH accreditations to ensure clinical accuracy. Beyond routine testing, the center integrates specialized services such as genomics, cardiology screenings, and preventive health packages. By utilizing sophisticated medical technology and a research-driven approach, the company provides critical diagnostic support to patients and healthcare practitioners.

Recent filings

Filing Released Lang Actions
Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Pursuant ....
Regulatory Filings Classification · 75% confidence The document is a formal notice under Regulation 29 of SEBI LODR announcing a forthcoming Board of Directors meeting to consider financial results and related matters. There is no actual financial data or report attached; it is a regulatory compliance disclosure rather than the report itself. It does not notify a change in board membership (so not MANG) nor is it a publication of a completed report (RPA). It best fits the catch-all category for general regulatory announcements and compliance filings: RNS.
2026-05-21 English
Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 for the year ended 31st March, 2026
Major Shareholding Notification Classification · 90% confidence The document is a formal letter to the stock exchange disclosing promoter and promoter group shareholding and encumbrance status under SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, specifically Regulation 31(4) for the year ended 31 March 2026. This corresponds to a notification of significant share ownership levels by promoters. It is not a full financial report or earnings release. Therefore, it should be classified as a Major Shareholding Notification.
2026-05-21 English
Pursuant to Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith the Monitoring Agency Report issued by CARE Ratings ....
Regulatory Filings Classification · 82% confidence The document is a regulatory submission under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 providing the Monitoring Agency Report on utilization of IPO proceeds for the year ended March 31, 2026. It is not a financial report like an annual or interim report, nor is it an earnings release, M&A announcement, share issuance notice, board or voting change, or specialized data supplement. It is a mandated compliance filing disclosing detailed utilization of funds, with no indication of simply announcing a report’s publication (RPA). Therefore, it falls under Regulatory Filings (RNS) as the appropriate catch‐all for miscellaneous compliance documents.
2026-05-15 English
In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting ....
Regulatory Filings Classification · 85% confidence The document is an exchange filing under SEBI LODR (Regulation 30 & 33) notifying the outcome of a board meeting. It does not contain substantive financial statements (so it’s not an Interim Report or Annual Report), nor does it announce management changes or a proxy solicitation. It is a routine regulatory announcement disclosing board resolutions and hence falls under the general “Regulatory Filings” category.
2026-05-13 English
Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve 1. TO CONSIDER ....
Board/Management Information Classification · 85% confidence The document is a formal notice under SEBI Listing Regulations informing the stock exchange of a scheduled Board of Directors meeting and its agenda items. This is a classic announcement of board-level corporate action, which falls under Board/Management Information.
2026-05-12 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the half year ended March 31, 2026
Regulatory Filings Classification · 85% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, provided to the stock exchange (BSE) by the company and its registrar and share transfer agent. It is primarily an officer certification/attestation confirming no demat/remat requests, rather than a substantive financial report or announcement. Such filings fall under general regulatory filings.
2026-05-02 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.